Table 1. Outcomes after treatment... | American Society of Hematology

Table 1.

Outcomes after treatment discontinuation

Subject	Age at enrollment (y)	MIPI risk	Best response	Treatment duration (mo)	Off-treatment duration (mo)	Disease progression (yes/no)	Subsequent therapy	Survival status	OS (mo)
1	75	6.1	CR	101	≥21	No	—	Alive	≥122
2	68	5.8	CR	38	7	No	—	Deceased∗	45
3	56	6.0	CR	90	≥31	No	—	Alive	≥121
4	53	5.3	CR	84	≥33	No	—	Alive	≥117
5	50	5.4	CR	101	≥17	No	—	Alive	≥118
6	56	5.4	CR	36	≥79	No	—	Alive	≥115
7	66	5.8	CR	38	≥77	No	—	Alive	≥115
8	83	6.7	CR	29	30	Yes	Radiation	Deceased†	59
9	76	6.2	CR	51	≥1	No	—	Alive	≥52
10	66	5.9	CR	46	≥18	No	—	Alive	≥64
11	82	6.4	CR	37	≥22	No	—	Alive	≥59
12	55	5.7	CR	44	≥52	No	—	Alive	≥96

Subject	Age at enrollment (y)	MIPI risk	Best response	Treatment duration (mo)	Off-treatment duration (mo)	Disease progression (yes/no)	Subsequent therapy	Survival status	OS (mo)
1	75	6.1	CR	101	≥21	No	—	Alive	≥122
2	68	5.8	CR	38	7	No	—	Deceased∗	45
3	56	6.0	CR	90	≥31	No	—	Alive	≥121
4	53	5.3	CR	84	≥33	No	—	Alive	≥117
5	50	5.4	CR	101	≥17	No	—	Alive	≥118
6	56	5.4	CR	36	≥79	No	—	Alive	≥115
7	66	5.8	CR	38	≥77	No	—	Alive	≥115
8	83	6.7	CR	29	30	Yes	Radiation	Deceased†	59
9	76	6.2	CR	51	≥1	No	—	Alive	≥52
10	66	5.9	CR	46	≥18	No	—	Alive	≥64
11	82	6.4	CR	37	≥22	No	—	Alive	≥59
12	55	5.7	CR	44	≥52	No	—	Alive	≥96

Patient passed away from complications due to West Nile virus infection while in remission.

Patient received palliative radiation after disease progression.